Regression of chronic posterior leukoencephalopathy after stop of methotrexate treatment

Neurological Sciences

Volumn 30, Issue 5, 2009, Pages 375-378

  Marcon, Gabriella ^a,b   Giovagnoli, Anna Rita ^a   Mangiapane, Paola ^a   Erbetta, Alessandra ^a   Tagliavini, Fabrizio ^a   Girotti, Floriano ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Chronic posterior leukoencephalopathy; Cognitive disorders; Methotrexate therapy; PRLE; Psoriasic spondylarthritis

Indexed keywords

METHOTREXATE;

AGED; APRAXIA; ARTICLE; BLOOD EXAMINATION; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHRONIC DRUG ADMINISTRATION; COGNITIVE DEFECT; DEPTH PERCEPTION; DRUG WITHDRAWAL; DYSGRAPHIA; GENETIC ANALYSIS; HEMIPARESIS; HUMAN; HYPERREFLEXIA; LOW DRUG DOSE; MALE; NEUROLOGIC DISEASE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PSORIATIC ARTHRITIS; VISUAL DISORDER;

ADMINISTRATION, ORAL; APRAXIA, IDEOMOTOR; CEREBRAL CORTEX; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MALE; METHOTREXATE; MIDDLE AGED; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; PSORIASIS; REMISSION, SPONTANEOUS; TREATMENT OUTCOME;

EID: 70349652085     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-009-0119-6     Document Type: Article

References (13)

1. Joong-Seok K, Kwang-Soo L, Sung-Chul L et al (2007) Reversible posterior leukoencephalopathy syndrome in a patient with multiple system atrophy: a possible association with oral midodrine treatment. Mov Disord 22:1043-1046
2. Renard D, Westhovens R, Vandenbussche E et al (2004) Reversible posterior leukoencephalopathy during oral treatment with methotrexate. J Neurol 251:226-228
3. Grosflam J, Weinblatt ME (1991) Methotrexate: Mechanism of action, pharmacokinetics, clinical indications and toxicity. Curr Opin Rheumatol 3:363-368
4. Rondot P, de Recondo J, Ribadeau Dumas JL (1977) Visuomotor ataxia. Brain 100:355-376
5. Habib R, McIntosh AR, Wheeler MA, Tulving E (2003) Memory encoding and hippocampally-based novelty/familiarity discrimination networks. Neuropsychologia 41:271-279
6. Markowsky SJ, Zimmermann CL, Tholl D et al (1991) Methotrexate disposition following disruption of the blood brain barrier. Ther Drug Monit 13:24-31
7. Rubnitz E, Relling MV, Harrison PL et al (1998) Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia. Leukemia 12:1176-1181
8. Posner JB (1995) Side effects of chemotherapy. Neurologic complications of cancer. FA Davis, Philadelphia, pp 282-310
9. Rubinstein LJ, Herman MM, Long TF et al (1975) Disseminated necrotizing encephalopathy: A complication of treated central nervous system leukaemia and lymphoma. Cancer 35:291-305
10. Garg RK (2001) Posterior leukoencephalopathy syndrome. Postgrad Med F 77:24-28
11. Gijtenbeek JM, van den Bent MJ, Vecht CJ (1999) Cyclosporine neurotoxicity: A review. J Neurol 246:339-346
12. Schwartz RB, Jones KM, Kalina P et al (1992) Hypertensive encephalopathy: Findings on CT, MR imaging and SPECT imaging in 14 cases. AJR Am J Roentgenol 159:379-383
13. Filley CM, Kleinschmidt-DeMasters BK (2001) Toxic leukoencephalopathy. N Engl J Med 345:425-432